サマリー

世界のジェネリック医薬品市場規模は、2022年に3,436億米ドルに達しました。今後、IMARC Groupは、2023年から2028年の間に6.83%の成長率（CAGR）を示し、2028年までに4605億米ドルに達すると予測しています。

ジェネリック医薬品は、先発医薬品と生物学的に同等であり、同じ有効成分で同等の治療効果があります。また、用量、危険性、結果、副作用、強度、使用目的、投与経路も同様である。これらの医薬品は、製造に大規模な研究を必要としないため、先発医薬品よりも比較的安価です。さらに、ジェネリック医薬品の製造には、薬の有効性と安全性を測定するための臨床試験や動物実験を繰り返す必要がありません。その結果、ジェネリック医薬品は世界中で絶大な支持を集めています。

ジェネリック医薬品の市場動向：

高齢者人口の増加や、がん、糖尿病、心血管疾患などの慢性疾患の増加が、市場にプラスの影響を与える主な要因の一つとなっています。また、食生活の変化や多忙なスケジュールが様々な症状を引き起こし、それがジェネリック医薬品の世界的な需要を喚起しています。また、医療費削減やジェネリック医薬品の製造・普及を促進するための各国政府の取り組みが活発化していることも、市場の成長に寄与しています。また、効果的なジェネリック医薬品を導入し、簡単に入手できるようにすることが、主要企業の後押しとなっています。これとは別に、ジェネリック医薬品の製造コストが低いことも、市場に明るい展望をもたらしています。さらに、製薬会社や医療機関の世界的な拡大が、市場の成長をさらに後押ししています。さらに、大手メーカーが新製品を発売するためのパートナーシップ戦略に注力するようになったことが、市場の成長を後押ししています。さらに、大規模な研究開発（R&D）活動への投資の増加や医薬品の処方における技術の進歩が、市場を牽引すると予想されます。

主要な市場セグメント：

IMARC Groupは、世界のジェネリック医薬品市場レポートの各サブセグメントにおける主要トレンドの分析と、2023年から2028年までの世界および国レベルでの予測を提供しています。当レポートでは、市場を治療領域、ドラッグデリバリー、流通チャネルに基づき分類しています。

治療領域別の内訳：

中枢神経系
心血管系
皮膚科学
泌尿器・ホルモン
呼吸器
リウマチ科
糖尿病
オンコロジー
その他

中枢神経系（CNS）は、世界中で脳や脊髄の病気が増加していることから、主要な治療分野となっています。

ドラッグデリバリーによるブレークアップ：

オーラル
インジェクタブル
経皮・外用
吸入器

経口薬は、その便利な投与方法から、最も好まれる薬物送達形態であり、最小限の医療支援を必要とするものです。

流通チャネル別構成比：

小売薬局
病院内薬局

現在、ジェネリック医薬品の多くは一般用医薬品であり、処方箋を必要としないことから、小売薬局の店舗で流通しています。

国別構成比：

ユーエスエー
中国
ブラジル
ドイツ
フランス
インド
イギリス
日本
カナダ
イタリア
その他

米国は、ジェネリック医薬品の製造とアクセスを改善するために、政府当局が実施した多くの取り組みにより、市場で明確な優位性を示しています。

競合の状況：

市場は大小さまざまなメーカーが存在するため、その性質上、断片化されている。市場で活動している主要なプレーヤーには、Teva Pharmaceuticals Industries Ltd., Mylan N.V., Novartis AG, Pfizer Inc., Sun Pharmaceutical Industries Ltd., Fresenius SE & Co., Lupin Limited, Endo Pharmaceuticals Inc., Aurobindo Pharma Limited, and Aspen Pharmacare Holdings Limitedなどがあります。

本レポートで回答した主な質問

1.2022年のジェネリック医薬品の世界市場規模は？
2.2023年～2028年のジェネリック医薬品の世界市場の予想成長率は？
3.世界のジェネリック医薬品市場を牽引する主要因は何か？
4.COVID-19が世界のジェネリック医薬品市場に与えた影響とは？
5.ジェネリック医薬品の世界市場における治療分野別の内訳は？
6.ジェネリック医薬品の世界市場において、ドラッグデリバリーに基づく内訳は？
7.ジェネリック医薬品の世界市場の流通チャネル別の内訳はどうなっていますか？
8.世界のジェネリック医薬品市場の主要地域は？
9.世界のジェネリック医薬品市場における主要プレイヤー/企業は？

ページTOPに戻る

目次

1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Generic Drugs Industry
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Breakup by Country
5.5 Market Breakup by Therapy Area
5.6 Market Breakup by Drug Delivery
5.7 Market Breakup by Distribution Channel
5.8 Market Forecast
5.9 SWOT Analysis
5.9.1 Overview
5.9.2 Strengths
5.9.3 Weaknesses
5.9.4 Opportunities
5.9.5 Threats
5.10 Value Chain Analysis
5.10.1 Research and Development
5.10.2 Manufacturing
5.10.3 Marketing and Distribution
5.11 Porter’s Five Forces Analysis
5.11.1 Overview
5.11.2 Bargaining Power of Buyers
5.11.3 Bargaining Power of Suppliers
5.11.4 Degree of Competition
5.11.5 Threat of New Entrants
5.11.6 Threat of Substitutes
5.12 Regulations in the Generic Industry
5.13 Key Market Drivers and Success Factors
6 Performance of Key Countries
6.1 United States
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 China
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Brazil
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Germany
6.4.1 Market Trends
6.4.2 Market Forecast
6.5 France
6.5.1 Market Trends
6.5.2 Market Forecast
6.6 India
6.6.1 Market Trends
6.6.2 Market Forecast
6.7 United Kingdom
6.7.1 Market Trends
6.7.2 Market Forecast
6.8 Japan
6.8.1 Market Trends
6.8.2 Market Forecast
6.9 Canada
6.9.1 Market Trends
6.9.2 Market Forecast
6.10 Italy
6.10.1 Market Trends
6.10.2 Market Forecast
6.11 Others
6.11.1 Market Trends
6.11.2 Market Forecast
7 Market Breakup by Therapy Area
7.1 Central Nervous System
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Cardiovascular
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Dermatology
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Genitourinary/Hormonal
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 Respiratory
7.5.1 Market Trends
7.5.2 Market Forecast
7.6 Rheumatology
7.6.1 Market Trends
7.6.2 Market Forecast
7.7 Diabetes
7.7.1 Market Trends
7.7.2 Market Forecast
7.8 Oncology
7.8.1 Market Trends
7.8.2 Market Forecast
7.9 Others
7.9.1 Market Trends
7.9.2 Market Forecast
8 Market Breakup by Drug Delivery
8.1 Oral
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Injectables
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Dermal/Topical
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Inhalers
8.4.1 Market Trends
8.4.2 Market Forecast
9 Market Breakup by Distribution Channel
9.1 Retail Pharmacies
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Hospital Pharmacies
9.2.1 Market Trends
9.2.2 Market Forecast
10 Competitive Landscape
10.1 Market Structure
10.2 Market Breakup by Key Players
10.3 Key Player Profiles
10.3.1 Teva Pharmaceuticals Industries Ltd.
10.3.2 Mylan N.V.
10.3.3 Novartis AG
10.3.4 Pfizer Inc.
10.3.5 Sun Pharmaceutical Industries Ltd.
10.3.6 Fresenius SE & Co.
10.3.7 Lupin Limited
10.3.8 Endo Pharmaceuticals Inc.
10.3.9 Aurobindo Pharma Limited
10.3.10 Aspen Pharmacare Holdings Limited
11 Generic Drugs Manufacturing Process
11.1 Product Overview
11.2 Detailed Process Flow (Tablets)
11.3 Detailed Process Flow (Injectable)
11.4 Various Types of Unit Operations Involved
11.5 Mass Balance and Raw Material Requirements
12 Project Details, Requirements and Costs Involved
12.1 Land Requirements and Expenditures
12.2 Construction Requirements and Expenditures
12.3 Plant Machinery
12.4 Machinery Pictures
12.5 Raw Material Requirements and Expenditures
12.6 Packaging Requirements and Expenditures
12.7 Transportation Requirements and Expenditures
12.8 Utility Requirements and Expenditures
12.9 Manpower Requirements and Expenditures
12.10 Other Capital Investments
13 Loans and Financial Assistance
14 Project Economics
14.1 Capital Cost of the Project
14.2 Techno-Economic Parameters
14.3 Product Pricing and Margins Across Various Levels of the Supply Chain
14.4 Taxation and Depreciation
14.5 Income Projections
14.6 Expenditure Projections
14.7 Financial Analysis
14.8 Profit Analysis

List of Figure

Figure 1: Global: Generic Drugs Market: Major Drivers and Challenges
Figure 2: Global: Generic Drugs Market: Sales Value (in Billion US$), 2017-2022
Figure 3: Global: Generic Drugs Market Forecast: Sales Value (in Billion US$), 2023-2028
Figure 4: Global: Generic Drugs Market: Breakup by Country (in %), 2022
Figure 5: Global: Generic Drugs Market: Breakup by Therapy Area (in %), 2022
Figure 6: Global: Generic Drugs Market: Breakup by Drug Delivery (in %), 2022
Figure 7: Global: Generic Drugs Market: Breakup by Distribution Channel (in %), 2022
Figure 8: Global: Generic Drugs Industry: SWOT Analysis
Figure 9: Global: Generic Drugs Industry: Value Chain Analysis
Figure 10: Global: Generic Drugs Industry: Porter’s Five Forces Analysis
Figure 11: USA: Generic Drugs Market (in Million US$), 2017 & 2022
Figure 12: USA: Generic Drugs Market Forecast (in Million US$), 2023-2028
Figure 13: China: Generic Drugs Market (in Million US$), 2017 & 2022
Figure 14: China: Generic Drugs Market Forecast (in Million US$), 2023-2028
Figure 15: Brazil: Generic Drugs Market (in Million US$), 2017 & 2022
Figure 16: Brazil: Generic Drugs Market Forecast (in Million US$), 2023-2028
Figure 17: Germany: Generic Drugs Market (in Million US$), 2017 & 2022
Figure 18: Germany: Generic Drugs Market Forecast (in Million US$), 2023-2028
Figure 19: France: Generic Drugs Market (in Million US$), 2017 & 2022
Figure 20: France: Generic Drugs Market Forecast (in Million US$), 2023-2028
Figure 21: India: Generic Drugs Market (in Million US$), 2017 & 2022
Figure 22: India: Generic Drugs Market Forecast (in Million US$), 2023-2028
Figure 23: United Kingdom: Generic Drugs Market (in Million US$), 2017 & 2022
Figure 24: United Kingdom: Generic Drugs Market Forecast (in Million US$), 2023-2028
Figure 25: Japan: Generic Drugs Market (in Million US$), 2017 & 2022
Figure 26: Japan: Generic Drugs Market Forecast (in Million US$), 2023-2028
Figure 27: Canada: Generic Drugs Market (in Million US$), 2017 & 2022
Figure 28: Canada: Generic Drugs Market Forecast (in Million US$), 2023-2028
Figure 29: Italy: Generic Drugs Market (in Million US$), 2017 & 2022
Figure 30: Italy: Generic Drugs Market Forecast (in Million US$), 2023-2028
Figure 31: Others: Generic Drugs Market (in Million US$), 2017 & 2022
Figure 32: Others: Generic Drugs Market Forecast (in Million US$), 2023-2028
Figure 33: Global: Generic Drugs Market: Oral (in Million US$), 2017 & 2022
Figure 34: Global: Generic Drugs Market Forecast: Oral (in Million US$), 2023-2028
Figure 35: Global: Generic Drugs Market: Injectables (in Million US$), 2017 & 2022
Figure 36: Global: Generic Drugs Market Forecast: Injectables (in Million US$), 2023-2028
Figure 37: Global: Generic Drugs Market: Dermal/Topical (in Million US$), 2017 & 2022
Figure 38: Global: Generic Drugs Market Forecast: Dermal/Topical (in Million US$), 2023-2028
Figure 39: Global: Generic Drugs Market: Inhalers (in Million US$), 2017 & 2022
Figure 40: Global: Generic Drugs Market Forecast: Inhalers (in Million US$), 2023-2028
Figure 41: Global: Generic Drugs Market: Central Nervous System (in Million US$), 2017 & 2022
Figure 42: Global: Generic Drugs Market Forecast: Central Nervous System (in Million US$), 2023-2028
Figure 43: Global: Generic Drugs Market: Cardiovascular (in Million US$), 2017 & 2022
Figure 44: Global: Generic Drugs Market Forecast: Cardiovascular (in Million US$), 2023-2028
Figure 45: Global: Generic Drugs Market: Dermatology (in Million US$), 2017 & 2022
Figure 46: Global: Generic Drugs Market Forecast: Dermatology (in Million US$), 2023-2028
Figure 47: Global: Generic Drugs Market: Genitourinary/Hormonal (in Million US$), 2017 & 2022
Figure 48: Global: Generic Drugs Market Forecast: Genitourinary/Hormonal (in Million US$), 2023-2028
Figure 49: Global: Generic Drugs Market: Respiratory (in Million US$), 2017 & 2022
Figure 50: Global: Generic Drugs Market Forecast: Respiratory (in Million US$), 2023-2028
Figure 51: Global: Generic Drugs Market: Rheumatology (in Million US$), 2017 & 2022
Figure 52: Global: Generic Drugs Market Forecast: Rheumatology (in Million US$), 2023-2028
Figure 53: Global: Generic Drugs Market: Diabetes (in Million US$), 2017 & 2022
Figure 54: Global: Generic Drugs Market Forecast: Diabetes (in Million US$), 2023-2028
Figure 55: Global: Generic Drugs Market: Oncology (in Million US$), 2017 & 2022
Figure 56: Global: Generic Drugs Market Forecast: Oncology (in Million US$), 2023-2028
Figure 57: Global: Generic Drugs Market: Other Therapy Areas (in Million US$), 2017 & 2022
Figure 58: Global: Generic Drugs Market Forecast: Other Therapy Areas (in Million US$), 2023-2028
Figure 59: Global: Generic Drugs Market: Retail Pharmacies (in Million US$), 2017 & 2022
Figure 60: Global: Generic Drugs Market Forecast: Retail Pharmacies (in Million US$), 2023-2028
Figure 61: Global: Generic Drugs Market: Hospital Pharmacies (in Million US$), 2017 & 2022
Figure 62: Global: Generic Drugs Market Forecast: Hospital Pharmacies (in Million US$), 2023-2028
Figure 63: Generic Drugs Industry: Profit Margins at Various Levels of the Supply Chain
Figure 64: Generic Drugs Manufacturing: Production Cost Breakup (in %)
Figure 65: Generic Drugs Manufacturing: Detailed Process Flow
Figure 66: Generic Drugs Manufacturing Process: Conversion Rate of Feedstocks
Figure 67: Generic Drugs Manufacturing: Proposed Plant Layout
Figure 68: Generic Drugs Manufacturing Plant: Breakup of Capital Costs (in %)

List of Table

Table 1: Global: Generic Drugs Market: Key Industry Highlights, 2022 and 2028
Table 2: Global: Generic Drugs Market Forecast: Breakup by Country (in Million US$), 2023-2028
Table 3: Global: Generic Drugs Market Forecast: Breakup by Therapy Area (in Million US$), 2023-2028
Table 4: Global: Generic Drugs Market Forecast: Breakup by Drug Delivery (in Million US$), 2023-2028
Table 5: Global: Generic Drugs Market Forecast: Breakup by Distribution Channel (in Million US$), 2023-2028
Table 6: Generic Drugs Market: Competitive Structure
Table 7: Generic Drugs Market: Key Players
Table 8: Generic Drugs Manufacturing Plant: Costs Related to Land and Site Development (in US$)
Table 9: Generic Drugs Manufacturing Plant: Costs Related to Civil Works (in US$)
Table 10: Generic Drugs Manufacturing Plant: Costs Related to Machinery Unit (in US$)
Table 11: Generic Drugs Manufacturing Plant: Raw Material Requirements
Table 12: Generic Drugs Manufacturing Plant: Costs Related to Salaries and Wages (in US$)
Table 13: Generic Drugs Manufacturing Plant: Costs Related to Other Capital Investments (in US$)
Table 14: Details of Financial Assistance Offered by Financial Institutions
Table 15: Generic Drugs Manufacturing Plant: Capital Costs (in US$)
Table 16: Generic Drugs Manufacturing Plant: Techno-Economic Parameters
Table 17: Generic Drugs Manufacturing Plant: Taxation and Depreciation (in US$)
Table 18: Generic Drugs Manufacturing Plant: Income Projections (in US$)
Table 19: Generic Drugs Manufacturing Plant: Expenditure Projections (in US$)
Table 20: Generic Drugs Manufacturing Plant: Cash Flow Analysis Without Considering the Income Tax Liability (in US$)
Table 21: Generic Drugs Manufacturing Plant: Cash Flow Analysis on Considering the Income Tax Liability (in US$)
Table 22: Generic Drugs Manufacturing Plant: Profit and Loss Account (in US$)